nach oben

Erschienen in:

08.02.2018 | Commentary

Geospatial approaches to cancer control and population sciences at the United States cancer centers

verfasst von: Robert W. Korycinski, Bethany L. Tennant, Michelle A. Cawley, Bonny Bloodgood, April Y. Oh, David Berrigan

Erschienen in: Cancer Causes & Control | Ausgabe 3/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Geospatial, contextual, and multilevel research is integral to cancer prevention and control. NCI-designated Cancer Centers are at the forefront of cancer research; therefore, this paper sought to review the geospatial, contextual, and multilevel research at these cancer centers.

Methods

Investigators used PubMed and Web of Science to compile geospatial publications from 1971 to February 2016 with cancer center-affiliated authors. Relevant abstracts were pulled and classified by six geospatial approaches, eight geospatial scales, and eight cancer sites.

Results

The searches identified 802 geospatial, contextual, and multilevel publications with authors affiliated at 60 of the 68 NCI-designated Cancer Centers. Over 90% were published after 2000. Five cancer centers accounted for approximately 50% of total publications, and 30 cancer centers accounted for over 85% of total publications. Publications covered all geospatial approaches and scales to varying degrees, and 90% dealt with cancer.

Conclusions

The NCI-designated Cancer Center network is increasingly pursuing geospatial, contextual, and multilevel cancer research, although many cancer centers still conduct limited to no research in this area. Expanding geospatial efforts to research programs across all cancer centers will further enrich cancer prevention and control. Similar reviews may benefit other domestic and international cancer research institutions.

Nur mit Berechtigung zugänglich

Richardson DB, Volkow ND, Kwan MP, Kaplan RM, Goodchild MF, Croyle RT (2013) Spatial turn in health research. Science 339:1390–1392. https://doi.org/10.1126/science.1232257 CrossRefPubMedPubMedCentral

Schootman M, Gomez SL, Henry KA, Paskett ED, Ellison GL, Oh A, Taplin SH, Tatalovich Z, Berrigan DA (2017) Geospatial approaches to cancer control and population sciences. Cancer Epidemiol Biomarkers Prev 26:472–475. https://doi.org/10.1158/1055-9965.EPI-17-0104 CrossRefPubMedPubMedCentral

Krieger N, Chen JT, Waterman PD, Soobader MJ, Subramanian SV, Carson R (2002) Geocoding and monitoring of US socioeconomic inequalities in mortality and cancer incidence: does the choice of area-based measure and geographic level matter?: the Public Health Disparities Geocoding Project. Am J Epidemiol 156:471–482. https://doi.org/10.1093/aje/kwf068 CrossRefPubMed

Burbank F (1971) Patterns in cancer mortality in the United States: 1950–1967. Natl Cancer Inst Monogr 71:1–594PubMed

Mason TJ, McKay FW, Hoover R, Blot WJ, Fraumeni JF Jr (1975) Atlas of Cancer Mortality for U.S. Counties: 1950–1969. U.S. Department of Health, Education, and Welfare. https://archive.org/details/atlasofcancermor00nati_0. Accessed 14 August 2017

Mason TJ, McKay FW (1974) U.S. Cancer Mortality by County: 1950–1969. U.S. Department of Health, Education, and Welfare. https://catalog.hathitrust.org/Record/011324517. Accessed 14 Aug 2017

National Cancer Institute (n.d.) About the SEER program. https://seer.cancer.gov/about/index.html. Accessed 22 May 2017

National Cancer Institute (n.d.) Geographic information systems and science for cancer control. https://gis.cancer.gov/. Accessed 22 May 2017

National Cancer Institute, Centers for Disease Control and Prevention (n.d.) State cancer profiles. https://statecancerprofiles.cancer.gov/index.html. Accessed 22 May 2017

10.

Forman D, Bray F, Brewster DH, Gombe Mbalawa C, Kohler B, Piñeros M, Steliarova-Foucher E, Swaminathan R, Ferlay J (2014) Cancer incidence in five continents volume X. IARC Scientific Publications. http://publications.iarc.fr/Book-And-Report-Series/Iarc-Scientific-Publications/Cancer-Incidence-In-Five-Continents-Volume-X-2014. Accessed 15 Aug 2017

11.

Boyle P, Smans M (2008) Atlas of cancer mortality in the European Union and the European Economic Area 1993–1997. IARC Scientific Publications. http://publications.iarc.fr/Book-And-Report-Series/Iarc-Scientific-Publications/Atlas-Of-Cancer-Mortality-In-The-European-Union-And-The-European-Economic-Area-1993-1997-2008. Accessed 15 Aug 2017

12.

International Agency for Research on Cancer (n.d.) Cancer today. http://gco.iarc.fr/today/home. Accessed 15 August 2017

13.

Li K, Lin GZ, Li Y, Dong H, Xu H, Song SF, Liang YR, Liu HZ (2017) Spatio-temporal analysis of the incidence of colorectal cancer in Guangzhou, 2010–2014. Chin J Cancer 36:60. https://doi.org/10.1186/s40880-017-0231-6 CrossRefPubMedPubMedCentral

14.

McNally RJ, Basta NO, Errington S, James PW, Norman PD, Hale JP, Pearce MS (2015) Socioeconomic patterning in the incidence and survival of teenage and young adult men aged between 15 and 24 years diagnosed with non-seminoma testicular cancer in northern England. Urol Oncol 33:506. https://doi.org/10.1016/j.urolonc.2015.07.014 CrossRefPubMed

15.

Yanagi Y, de Assunção JV, Barrozo LV (2012) The impact of atmospheric particulate matter on cancer incidence and mortality in the city of São Paulo, Brazil. Cad Saude Publica 28:1737–1748. https://doi.org/10.1590/S0102-311X2012000900012 CrossRefPubMed

16.

National Cancer Institute (n.d.) NCI-designated cancer centers. https://www.cancer.gov/research/nci-role/cancer-centers. Accessed 22 May 2017

17.

Polissar L (1980) The effect of migration on comparison of disease rates in geographic studies in the United States. Am J Epidemiol 111:175–182. https://doi.org/10.1093/oxfordjournals.aje.a112885 CrossRefPubMed

18.

Onega T, Cook A, Kirlin B, Shi X, Alford-Teaster J, Tuzzio L, Buist DS (2011) The influence of travel time on breast cancer characteristics, receipt of primary therapy, and surveillance mammography. Breast Cancer Res Treat 129:269–275. https://doi.org/10.1007/s10549-011-1549-4 CrossRefPubMedPubMedCentral

19.

Norsted TL, White E (1989) Cancer incidence among native Americans of western Washington. Int J Epidemiol 18:22–27. https://doi.org/10.1093/ije/18.1.22 CrossRefPubMed

20.

Eberth JM, Zhang X, Hossain M, Tiro JA, Holt JB, Vernon SW (2013) County-level estimates of human papillomavirus vaccine coverage among young adult women in Texas, 2008. Tex Public Health J 65:37–40PubMedPubMedCentral

21.

Lamont EB, Hayreh D, Pickett KE, Dignam JJ, List MA, Stenson KM, Haraf DJ, Brockstein BE, Sellergren SA, Vokes EE (2003) Is patient travel distance associated with survival on phase II clinical trials in oncology? J Natl Cancer Inst 95:1370–1375. https://doi.org/10.1093/jnci/djg035 CrossRefPubMed

22.

Kinney AY, Harrell J, Slattery M, Martin C, Sandler RS (2006) Rural-urban differences in colon cancer risk in blacks and whites: the North Carolina Colon Cancer Study. J Rural Health 22:124–130. https://doi.org/10.1111/j.1748-0361.2006.00021.x CrossRefPubMed

23.

Henry KA, Sherman RL, McDonald K, Johnson CJ, Lin G, Stroup AM, Boscoe FP (2014) Associations of census-tract poverty with subsite-specific colorectal cancer incidence rates and stage of disease at diagnosis in the United States. J Cancer Epidemiol. https://doi.org/10.1155/2014/823484 CrossRefPubMedPubMedCentral

24.

Carlos HA, Shi X, Sargent J, Tanski S, Berke EM (2010) Density estimation and adaptive bandwidths: a primer for public health practitioners. Int J Health Geogr 9:39. https://doi.org/10.1186/1476-072X-9-39 CrossRefPubMedPubMedCentral

25.

Danysh HE, Mitchell LE, Zhang K, Scheurer ME, Lupo P (2015) Traffic-related air pollution and the incidence of childhood central nervous system tumors: Texas, 2001–2009. Pediatr Blood Cancer 62:1572–1578. https://doi.org/10.1002/pbc.25549 CrossRefPubMed

26.

Goodchild MF (2015) Space, place and health. Ann GIS 21:97–100. https://doi.org/10.1080/19475683.2015.1007895 CrossRef

27.

Krieger N (2017) Follow the North Star: why space, place, and power matter for geospatial approaches to cancer control and health equity. Cancer Epidemiol Biomark Prev 26:476–479. https://doi.org/10.1158/1055-9965.EPI-16-1018 CrossRef

28.

National Cancer Institute (2017) SEER-Medicare: required documents & instructions for submitting requests. https://healthcaredelivery.cancer.gov/seermedicare/obtain/requests.html. Accessed 20 December 2017

29.

Richardson DB, Kwan MP, Alter G, McKendry JE (2015) Replication of scientific research: addressing geoprivacy, confidentiality, and data sharing challenges in geospatial research. Ann GIS 21:101–110. https://doi.org/10.1080/19475683.2015.1027792 CrossRef

30.

Blue Ribbon Panel (2016) Cancer Moonshot Blue Ribbon Panel report 2016. https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/blue-ribbon-panel#ui-id-3. Accessed 1 June 2017

31.

National Cancer Institute (2016) Conference on geospatial approaches to cancer control and population sciences. https://epi.grants.cancer.gov/events/geospatial/. Accessed 2 June 2017

32.

Cancer Epidemiology B, Prevention (2017) Table of contents. http://cebp.aacrjournals.org/content/26/4. Accessed 2 June 2017

33.

Bemanian A, Beyer KMM (2017) Measures matter: the local exposure/isolation (LEx/Is) metrics and relationships between local-level segregation and breast cancer survival. Cancer Epidemiol Biomark Prev 26:516–524. https://doi.org/10.1158/1055-9965.EPI-16-0926 CrossRef

34.

Zhou Y, Bemanian A, Beyer KMM (2017) Housing discrimination, residential racial segregation, and colorectal cancer survival in southeastern Wisconsin. Cancer Epidemiol Biomark Prev 26:561–568. https://doi.org/10.1158/1055-9965.EPI-16-0929 CrossRef

35.

Nicholson LM, Leider J, Chriqui JF (2017) Exploring the linkage between activity-friendly zoning, inactivity, and cancer incidence in the United States. Cancer Epidemiol Biomark Prev 26:578–586. https://doi.org/10.1158/1055-9965.EPI-16-0331 CrossRef

36.

James P, Hart JE, Hipp JA, Mitchell JA, Kerr J, Hurvitz PM, Glanz K, Laden F (2017) GPS-based exposure to greenness and walkability and accelerometry-based physical activity. Cancer Epidemiol Biomark Prev 26:525–532. https://doi.org/10.1158/1055-9965.EPI-16-0925 CrossRef

37.

King AC, Winter SJ, Sheats JL et al (2016) Leveraging citizen science and information technology for population physical activity promotion. Transl J Am Coll Sports Med 1:30–44. https://doi.org/10.1249/TJX.0000000000000003 CrossRefPubMedPubMedCentral

38.

Rosas LG, Salvo D, Winter SJ, Cortes D, Rivera J, Rodriguez NM, King AC (2016) Harnessing technology and citizen science to support neighborhoods that promote active living in Mexico. J Urban Health 93:953–973. https://doi.org/10.1007/s11524-016-0081-6 CrossRefPubMedPubMedCentral

39.

Hall KL, Feng AX, Moser RP, Stokols D, Taylor BK (2008) Moving the science of team science forward: collaboration and creativity. Am J Prev Med 35:S243-S249. https://doi.org/10.1016/j.amepre.2008.05.007 CrossRefPubMedCentral

40.

Hall KL, Stokols D, Stipelman BA, Vogel AL, Feng A, Masimore B, Morgan G, Moser RP, Marcus SE, Berrigan D (2012) Assessing the value of team science: a study comparing center- and investigator-initiated grants. Am J Prev Med 42:157–163. https://doi.org/10.1016/j.amepre.2011.10.011 CrossRefPubMedPubMedCentral

Titel: Geospatial approaches to cancer control and population sciences at the United States cancer centers
verfasst von: Robert W. Korycinski
Bethany L. Tennant
Michelle A. Cawley
Bonny Bloodgood
April Y. Oh
David Berrigan
Publikationsdatum: 08.02.2018
Verlag: Springer International Publishing
Erschienen in: Cancer Causes & Control / Ausgabe 3/2018
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI: https://doi.org/10.1007/s10552-018-1009-0

Neu im Fachgebiet Onkologie

25.04.2024 | Nierenkarzinom | Nachrichten

Springer Medizin

Geospatial approaches to cancer control and population sciences at the United States cancer centers

Abstract

Purpose

Methods

Results

Conclusions

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2018

Participatory implementation science to increase the impact of evidence-based cancer prevention and control

A risk prediction model to allow personalized screening for cervical cancer

Non-communicable chronic diseases and timely breast cancer screening among women of the Eastern Caribbean Health Outcomes Research Network (ECHORN) Cohort Study

Glucosamine use and risk of colorectal cancer: results from the Cancer Prevention Study II Nutrition Cohort

Developing new age-specific prostate-specific antigen thresholds for testing for prostate cancer

Heterogeneous impacts: adverse childhood experiences and cancer screening

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie